publication venue for
- Examining the environmental risk factors of progressive¿onset and relapsing¿onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies. 472-485. 2024
- Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies 2023
- Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study. 3676-3681. 2022
- Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.. 1-6. 2019
- Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1. 2551-2555. 2013